Related Experiment Video
Updated: Dec 27, 2025

03:09
Author Spotlight: Advancing Structural and Biochemical Studies of Proteins Through Thermal Shift Assays
Published on: August 9, 2024
1.2K
Selenoprotein P; P for Plasma, Prognosis, Prophylaxis, and More
Ryouhei Tsutsumi1, Yoshiro Saito1
1Laboratory of Metabolism and Molecular Biology, Graduate School of Pharmaceutical Sciences, Tohoku University.
Biological & Pharmaceutical Bulletin
|March 3, 2020
Summary
Selenoprotein P (SeP) carries selenium and plays a key role in type 2 diabetes and pulmonary arterial hypertension. Emerging research highlights its potential as a therapeutic target for these diseases.
Area of Science:
- Biochemistry
- Human Physiology
- Pathophysiology
Background:
- Selenoprotein P (SeP) is a selenocysteine-containing protein primarily known for selenium transport.
- Traditional understanding positions SeP as a plasma carrier of selenium.
- Recent research suggests novel functions beyond selenium transport.
Purpose of the Study:
- To review the characteristics of Selenoprotein P.
- To summarize recent advances in SeP research.
- To focus on the emerging roles of SeP in human diseases and potential therapeutic applications.
Main Methods:
- Literature review of recent scientific studies.
- Analysis of pathophysiological roles of SeP.
- Discussion of potential medical and pharmaceutical applications.
Main Results:
- SeP has critical, previously unrecognized roles in human diseases.
- Type 2 diabetes mellitus (T2DM) and pulmonary arterial hypertension (PAH) are particularly implicated.
- SeP's functions extend beyond its role as a selenium carrier.
Conclusions:
- Selenoprotein P is implicated in the pathophysiology of T2DM and PAH.
- Further research into SeP's roles may reveal new therapeutic strategies.
- Targeting SeP presents potential medical and pharmaceutical opportunities.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
472
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
472
Cancer Survival Analysis
594
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
594

